DRUG
MECHANISM
USE
ADVERSE · NOTES
PPIs
omeprazole, pantoprazole, lansoprazole
Irreversible H⁺/K⁺-ATPase inhibition (prodrug activated by acid)
GERD, PUD, H. pylori, ZES, NSAID protection, stress ulcer prophylaxis
C. difficile, pneumonia, fractures, ↓ Mg²⁺, ↓ B12, AIN
Reversible H2 antagonists → ↓ basal and nocturnal acid
Mild GERD, PUD, urticaria (add-on)
Cimetidine: CYP inhibition, gynecomastia, ↑ creatinine (secretion block)
Neutralizes acid
Heartburn; phosphate binding
Constipation, hypophosphatemia, osteomalacia, neurotoxicity in CKD
Neutralizes acid
Heartburn, laxative
Diarrhea, hypermagnesemia (↓ reflexes) in CKD
Neutralizes acid
Heartburn, calcium supplement
Hypercalcemia, milk-alkali syndrome, rebound acid
Polymerizes in acid → binds ulcer base
PUD, stress ulcer prophylaxis
Needs acid (don't give with PPI/antacid); constipation, Al toxicity
Coats ulcer, antimicrobial vs H. pylori
H. pylori quadruple therapy, traveler's diarrhea
Black stool and tongue, salicylate effects
PGE₁ analog → ↑ mucus and bicarbonate, ↓ acid
NSAID-ulcer prevention, labor induction, abortion, PPH
Diarrhea, cramps; contraindicated in pregnancy (unless intended)
Somatostatin analog
Variceal bleeding, ZES, carcinoid, VIPoma
Gallstones
PPI + clarithromycin + amoxicillin (or metronidazole)
Low clarithromycin resistance areas
14 days; confirm eradication
PPI + bismuth + metronidazole + tetracycline
First-line in many settings, penicillin allergy
Disulfiram reaction with alcohol (metronidazole)
Potassium-competitive acid blocker
Erosive esophagitis, H. pylori
Faster onset than PPIs